https://www.pharmaceutical-technology.com/data-insights/mebufotenin-gh-research-unspecified-psychiatric-disorders-likelihood-of-approval/
Mebufotenin is under clinical development by GH Research and currently in Phase I for Unspecified Psychiatric Disorders.
psychiatric disordersmebufoteninghresearchunspecified